Published responses

Only answers from respondents who gave permission are published. However, all responses are included in the analysis of this activity.

Submissions recieved offline

Search responses

19 Published responses

Response 647432455
Australasian College of Dermatologists (ACD)
Response 254023827
Guy Klamer, Sydney Cord Blood Bank (on behalf of AusCord)
Gilead Sciences Pty Ltd
Daniel Mobasseri, Novotech Australia Pty Ltd
Bristol-Myers Squibb Australia Pty Ltd
the International Society for Cell and Gene Therapy
Rebecca Lim, Prescient Therapeutics
Geordie Clark, Revpar Pty Ltd
Response 603225309
Sylvia Roins, Novartis Pharmaceuticals Australia Pty Ltd
Medicines Australia
Response 181341874
Mirjana, BiomeBank
Dr Chih Wei Teng, CCRM Australia Ltd
Roche Products Pty Ltd
Biopharma Excellence, PharmaLex Pty Ltd (formerly ERA Consulting Pty Ltd)
Dr Christopher Rudge, Sara Attinger, Associate Professor Claire Hooker, Dr Claire Tanner, Professor Ian Kerridge, Professor Wendy Lipworth, Professor Cameron Stewart, Assistant Professor Tamra Lysaght, Professor Megan Munsie, This submission was prepared by the above-named investigators. Each of them is conducting research on the ethical, legal, and social implications and impacts of stem cell-based interventions as members of a team funded by a grant from the Australian Medical Research Future Fund Stem Cell Therapies Mission (APP2007623) called ‘Improving Decisions about Access to Stem Cell Interventions.’ The views contained in the responses below are those of the named authors only and do not represent the views of all investigators associated with the MRFF project.
Page 1 of 1